# A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).

> **NCT00576017** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag, S.A.** · enrollment: 19 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Fentanyl-TTS

## Key facts

- **NCT ID:** NCT00576017
- **Lead sponsor:** Janssen-Cilag, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576017, "A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00576017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*